Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Damien Gruson

Showing results (71-80 of 226) with videos related to

Pageof 23
Sort By:
Clinical Chemistry and Laboratory Medicine|April 24, 2020
Biotin interference: evaluation of a new generation of electrochemiluminescent immunoassays for high-sensitive troponin T and thyroid-stimulating hormone testingSamy Mzougui, Julien Favresse, Reza Soleimani, et al.
Clinical Chemistry and Laboratory Medicine|October 31, 2019
Macro vitamin B12: an underestimated threatReza Soleimani, Julien Favresse, Tatiana Roy, et al.
Future Cardiology|June 7, 2017
Elevation of plasma oncostatin M in heart failureDamien Gruson, Benjamin Ferracin, Sylvie A Ahn, et al.
Clinical Chemistry and Laboratory Medicine|September 26, 2016
Massive interference in free T4 and free T3 assays misleading clinical judgmentJulien Favresse, Henry Paridaens, Nathalie Pirson, et al.
International Journal of Cardiology|July 18, 2017
Head to head comparison of intact and C-terminal fibroblast growth factor 23 in heart failure patients with reduced ejection fractionDamien Gruson, Benjamin Ferracin, Sylvie A Ahn, et al.
Acta Diabetologica|November 7, 2013
What are the characteristics of phenotypic type 2 diabetic patients with low-titer GAD65 antibodies?Yovan P Mahadeb, Damien Gruson, Martin Buysschaert, et al.
International Journal of Cardiology|January 29, 2014
Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fractionDamien Gruson, Thibault Lepoutre, Sylvie A Ahn, et al.
International Journal of Cardiology|April 22, 2015
Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patientsDamien Gruson, Benjamin Ferracin, Sylvie A Ahn, et al.
International Journal of Cardiology|April 9, 2016
Soluble ST2, the vitamin D/PTH axis and the heart: New interactions in the air?Damien Gruson, Benjamin Ferracin, Sylvie A Ahn, et al.
Annals of Laboratory Medicine|October 16, 2020
Sustainability in Healthcare: Perspectives and Reflections Regarding Laboratory MedicineAroa Molero, Michele Calabrò, Maguelone Vignes, et al.
Pageof 23

Showing results (71-80 of 226) with videos related to

Sort By:
Pageof 23
Clinical Chemistry and Laboratory Medicine|April 24, 2020
Biotin interference: evaluation of a new generation of electrochemiluminescent immunoassays for high-sensitive troponin T and thyroid-stimulating hormone testingSamy Mzougui, Julien Favresse, Reza Soleimani, et al.
Clinical Chemistry and Laboratory Medicine|October 31, 2019
Macro vitamin B12: an underestimated threatReza Soleimani, Julien Favresse, Tatiana Roy, et al.
Future Cardiology|June 7, 2017
Elevation of plasma oncostatin M in heart failureDamien Gruson, Benjamin Ferracin, Sylvie A Ahn, et al.
Clinical Chemistry and Laboratory Medicine|September 26, 2016
Massive interference in free T4 and free T3 assays misleading clinical judgmentJulien Favresse, Henry Paridaens, Nathalie Pirson, et al.
International Journal of Cardiology|July 18, 2017
Head to head comparison of intact and C-terminal fibroblast growth factor 23 in heart failure patients with reduced ejection fractionDamien Gruson, Benjamin Ferracin, Sylvie A Ahn, et al.
Acta Diabetologica|November 7, 2013
What are the characteristics of phenotypic type 2 diabetic patients with low-titer GAD65 antibodies?Yovan P Mahadeb, Damien Gruson, Martin Buysschaert, et al.
International Journal of Cardiology|January 29, 2014
Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fractionDamien Gruson, Thibault Lepoutre, Sylvie A Ahn, et al.
International Journal of Cardiology|April 22, 2015
Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patientsDamien Gruson, Benjamin Ferracin, Sylvie A Ahn, et al.
International Journal of Cardiology|April 9, 2016
Soluble ST2, the vitamin D/PTH axis and the heart: New interactions in the air?Damien Gruson, Benjamin Ferracin, Sylvie A Ahn, et al.
Annals of Laboratory Medicine|October 16, 2020
Sustainability in Healthcare: Perspectives and Reflections Regarding Laboratory MedicineAroa Molero, Michele Calabrò, Maguelone Vignes, et al.
Pageof 23